STAT

FEBRUARY 9, 2024

WASHINGTON — A bipartisan group of senators is starting work on legislation to reform how Medicare pays physicians, they will announce Friday. Senate Minority Whip John Thune (R-S.D.) and Sens. Marsha Blackburn (R-Tenn.), John Barrasso (R-Wyo.), Debbie Stabenow (D-Mich.), Mark Warner (D-Va.), and Catherine Cortez Masto (D-Nev.) announced their intent to develop long-term fixes to issues with Medicare’s physician payment structure and to update the Medicare Access and CHIP Reauthori

298

298

PharmaVoice

FEBRUARY 9, 2024

After a big 2023, Yoshi Shitaka said the company is banking on gene therapies, KRAS degraders and more to keep the momentum.

264

264

STAT

FEBRUARY 9, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Our podcast this week centers exclusively on a tantalizing subject: Artificial intelligence in biotech. Give it a listen. Also, Moderna’s RSV vaccine efficacy seems lackluster compared to competitors, and the Bernie Sanders drug pricing song-and-dance did not seem to faze pharma CEOs.

Vaccines 264

Vaccines Drug Pricing Drug Development 264

The Pharmacist

FEBRUARY 9, 2024

Pharmacist access to patient records is ‘more urgent than ever’, Royal Pharmaceutical Society (RPS) director for Scotland Laura Wilson will tell new health secretary Neil Gray. This comes as Mr Gray replaces former cabinet secretary for NHS recovery, health and social care Michael Matheson, who resigned yesterday following an investigation into data roaming charges he […] The post Call for patient records access as new Scottish ministers appointed appeared first on The Pharmacist.

113

113

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 9, 2024

Aurobindo, which is one of the largest generic drug makers, has halted some production at a key facility in India after U.S. inspectors found manufacturing problems, the latest such episode to underscore concerns over both shortages and the quality of medicines produced by some suppliers. In a notice filed with the Bombay Stock Exchange, the company reported that the U.S.

263

263

pharmaphorum

FEBRUARY 9, 2024

Learn how implementing a SMART approach in stem cell manufacturing can lead to improved efficiency and cost reduction for the production of mesenchymal stem cells (MSCs) used in the treatment of osteoarthritic and autoimmune conditions.

111

111

pharmaphorum

FEBRUARY 9, 2024

The combination of drugs for hypertension and software to personalise dosing to an individual patient has been shown to deliver improved blood pressure control and adherence to therapy in a pilot study.

110

110

STAT

FEBRUARY 9, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

200

200

pharmaphorum

FEBRUARY 9, 2024

Measuring the success or failure of UK MedTech companies is complex and multi-faceted, but it is undoubtedly influenced by two significant factors. Read on to learn more.

109

109

FDA Law Blog: Biosimilars

FEBRUARY 9, 2024

By Adrienne R. Lenz, Principal Medical Device Regulation Expert & Lisa M. Baumhardt, Senior Medical Device Regulation Expert — As an end of the year gift, FDA finalized its guidance document, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations , in late December. We previously blogged on the draft guidance ( here ) and on FDA’s broader framework for Digital Health Technologies (DHT) ( here and here ).

Documentation 105

Documentation 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Commerce

FEBRUARY 9, 2024

Researchers explore the proportion of approved drugs in the Canadian marketplace that utilize manufacturer-sponsored patient support programs, along with the types of medications that are more likely to do so.

105

105

Pharma Times

FEBRUARY 9, 2024

The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy

139

139

pharmaphorum

FEBRUARY 9, 2024

Discover insights from Trevor Martin, the co-founder and CEO of Mammoth Biosciences, in an exclusive interview from JP Morgan for 2024. Gain valuable knowledge about Mammoth Biosciences and the future of biotech innovation.

95

95

Pharmaceutical Commerce

FEBRUARY 9, 2024

A dive into the intricacies of how to ensure a long-running event stays fresh and relevant to the needs of the pharmaceutical industry.

111

111

Pharmaceutical Technology

FEBRUARY 9, 2024

Pharma CEOs defended their high prescription drug costs, stating that the current prices are necessary for continued innovation.

Drug Pricing 113

Drug Pricing 113

Express Pharma

FEBRUARY 9, 2024

Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to manufacture and market Dexamethasone Tablets USP, 1 mg (USRLD: Dexamethasone Tablets). Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders.

Immunity 89

Immunity Immunization 89

Pharmaceutical Technology

FEBRUARY 9, 2024

AstraZeneca has reported a significant 81% rise in profit after tax, reaching $5.96bn for FY 2023 from $3.29bn in the previous year.

105

105

Pharma Times

FEBRUARY 9, 2024

OART is increasingly emerging to assess and adapt treatment for cancer patients

118

118

Pharmaceutical Technology

FEBRUARY 9, 2024

Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.

97

97

The Pharmacist

FEBRUARY 9, 2024

A proposal to subsidise prescriptions for e-cigarettes in an HRT certificate-style scheme has been mooted during a parliamentary inquiry. Professor Javed Khan, author of the Khan Review, ‘Making Smoking Obsolete’, gave evidence to the Health and Social Care Select Committee (HSCC), as part of an inquiry into preventing ill-health, on Monday. Professor Khan welcomed the […] The post Subsidising vapes on prescription ‘should be considered’, MPs told appeared first on The Pharmacist.

87

87

Pharmaceutical Technology

FEBRUARY 9, 2024

Nippon will pay $10m upfront and up to $275m in milestone-based payments for the developmental and commercial rights to Vicore’s C21 in Japan.

90

90

Drug Channels

FEBRUARY 9, 2024

Today’s guest post comes from Nasir Ali, Chief Product Officer at CareMetx. Nasir shares findings from CareMetx’s new 2024 Patient Services Report research study: Revealing Manufacturer Priorities: Patients Naturally Take Center Stage. As he explains, manufacturers want hub partners that can take a holistic approach and address each patient’s individual needs.

77

77

The Pharmacist

FEBRUARY 9, 2024

A report considering how HIV prevention drug Pre-Exposure Prophylaxis (PrEP) could be made available through community pharmacies will be published within days, the pharmacy minister has confirmed. In a parliamentary debate to mark national HIV testing week in the house of commons yesterday, Labour MP for Hammersmith Andrew Slaughter highlighted issues around access to PrEP. […] The post Report considering pharmacy access to PrEP to come ‘next week’ appeared first on The Pharmacist.

Community Pharmacies 85

Community Pharmacies 85

EMCrit Project

FEBRUARY 9, 2024

The acute crit care med rec EMCrit Project by Scott Weingart, MD FCCM.

109

109

PharmaTech

FEBRUARY 9, 2024

The three non-commercial developers of ATMPs will benefit from enhanced support from the agency.

96

96

Pharmafile

FEBRUARY 9, 2024

BioNTech and Autolus Therapeutics have announced that they have entered a strategic collaboration intended to further both companies’ autologous CAR T programmes towards commercialisation following regulatory authorisations. The companies have also entered into a license and option agreement and a securities purchase agreement. BioNTech has agreed to purchase $200m of Autolos’ American Depositary Shares in […] The post BioNTech and Autolus announce CAR T-cell therapy collaboration appeared

68

68

BioPharma Dive

FEBRUARY 9, 2024

Shortly after Kyverna priced one of the sector’s largest IPOs in recent years, Maag spoke with BioPharma Dive about what it takes to go public now.

73

73

Pharmafile

FEBRUARY 9, 2024

Fresenius Medical Care has announced that it has received US Food and Drug Administration (FDA) 501(k) clearance for its 5008X Hemodialysis System. The company now intends to bring a new standard of care in dialysis treatment to patients with kidney diseases in the US. This clearance follows results from the recently published CONVINCE study, which […] The post Fresenius Medical Care gains FDA 501(k) clearance for haemodialysis system appeared first on Pharmafile.

63

63

BioPharma Dive

FEBRUARY 9, 2024

New results have convinced Takeda to “rapidly” pursue a late-stage program for its drug TAK-861 in one type of narcolepsy, while in another the company opted not to continue.

65

65

Drug Patent Watch

FEBRUARY 9, 2024

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting… The post New patent for Intra-cellular drug CAPLYTA appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmaceutical Business Review

FEBRUARY 9, 2024

The investment will also enable the company to enhance the outcomes in pharma manufacturing by scaling its operations and improve customer service. A growth equity fund specialising in pharmaceuticals and biotechnology service businesses, NewVale Capital, led the financing round. Current investors, including Atlantic Bridge, Uncork Capital and Crosslink Capital have also contributed to the funding, reaffirming their commitment to Aizon’s growth and the potential of AI in pharmaceutical man

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Customer Service 59

World Pharma News

FEBRUARY 9, 2024

Scientists at the UC San Francisco (UCSF) and Northwestern Medicine may have found a way around the limitations of engineered T cells by borrowing a few tricks from cancer itself. By studying mutations in malignant T cells that cause lymphoma, they zeroed in on one that imparted exceptional potency to engineered T cells. Inserting a gene encoding this unique mutation into normal human T cells made them more than 100 times more potent at killing cancer cells without any signs of becoming toxic.

62

62

Board Vitals - Pharmacist

FEBRUARY 9, 2024

Gearing up for the Radiology Core exam? While knowing specific diagnoses is helpful, the exam requires you to build upon these diagnoses. By taking the time to study some often overlooked topics, you will be ready to do your best come test day. What topics are on the Radiology Core Exam? The Radiology Qualifying (Core) Exam is designed to evaluate a candidate’s core fund of knowledge and clinical judgment across practice domains of diagnostic radiology and integrated interventional radiology/dia

52

52

RX Note

FEBRUARY 9, 2024

Introduction Vital signs are measurements of the body's most basic functions , hence providing valuable information concerning a patient's general state of health. Any abnormal values require further investigation and recheck. The 4 main vital signs routinely monitored by health care professionals are: Body temperature (BT) Pulse rate (PR) Respiration rate (RR) Blood pressure (BP) NOTE: The fifth vital sign may refer to a different parameters, such as pain , oxygen saturation and blood glucose.

Hospitals 52

Hospitals 52

Compounding Pharmacy of America

FEBRUARY 9, 2024

Many individuals take various supplements to improve their weight loss journey. This guide explains which ones are the most recommended. The post What Supplements Should I Take With Semaglutide? appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52